Related references
Note: Only part of the references are listed.Advances in the design of organometallic anticancer complexes
Pingyu Zhang et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2017)
An Organoruthenium Anticancer Agent Shows Unexpected Target Selectivity For Plectin
Samuel M. Meier et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
The metalation of hen egg white lysozyme impacts protein stability as shown by ion mobility mass spectrometry, differential scanning calorimetry, and X-ray crystallography
Matthew P. Sullivan et al.
CHEMICAL COMMUNICATIONS (2017)
First Crystal Structure for a Gold Carbene-Protein Adduct
Giarita Ferraro et al.
BIOCONJUGATE CHEMISTRY (2016)
Iridium(I) Compounds as Prospective Anticancer Agents: Solution Chemistry, Antiproliferative Profiles and Protein Interactions for a Series of Iridium(I) N-Heterocyclic Carbene Complexes
Yvonne Gothe et al.
CHEMISTRY-A EUROPEAN JOURNAL (2016)
The development of RAPTA compounds for the treatment of tumors
Benjamin S. Murray et al.
COORDINATION CHEMISTRY REVIEWS (2016)
Cisplatin binding to proteins: A structural perspective
Luigi Messori et al.
COORDINATION CHEMISTRY REVIEWS (2016)
Nanostructured materials functionalized with metal complexes: In search of alternatives for administering anticancer metallodrugs
Waseem A. Wani et al.
COORDINATION CHEMISTRY REVIEWS (2016)
Effect of temperature on the interaction of cisplatin with the model protein hen egg white lysozyme
Giarita Ferraro et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2016)
Anticancer activity of Ru- and Os(arene) compounds of a maleimide-functionalized bioactive pyridinecarbothioamide ligand
Muhammad Hanif et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2016)
X-ray Structure Analysis of Indazolium trans-[Tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019) Bound to Human Serum Albumin Reveals Two Ruthenium Binding Sites and Provides Insights into the Drug Binding Mechanism
Aleksandar Bijelic et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Anticancer Activity and Modes of Action of (arene) ruthenium(II) Complexes Coordinated to C-, N-, and O-ligands
Bernhard Biersack
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2016)
Bonding and Catalytic Application of Ruthenium N-Heterocyclic Carbene Complexes Featuring Triazole, Triazolylidene, and Imidazolylidene Ligands
Manuela Hollering et al.
ORGANOMETALLICS (2016)
Safety and activity of IT-139, a ruthenium-based compound, in patients with advanced solid tumours: a first-in- human, open-label, dose-escalation phase I study with expansion cohort
Howard A. Burris et al.
ESMO OPEN (2016)
Platinum(II) Complexes with O,S Bidentate Ligands: Biophysical Characterization, Antiproliferative Activity, and Crystallographic Evidence of Protein Binding
Carolin Muegge et al.
INORGANIC CHEMISTRY (2015)
Insights on the mechanism of thioredoxin reductase inhibition by Gold N-heterocyclic carbene compounds using the synthetic linear Selenocysteine containing C-terminal peptide hTrxR(488-499): An ESI-MS investigation
Alessandro Pratesi et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2014)
Opening the lid on piano-stool complexes: An account of ruthenium(II)-arene complexes with medicinal applications
Alexey A. Nazarov et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2014)
An overview of N-heterocyclic carbenes
Matthew N. Hopkinson et al.
NATURE (2014)
Ligand substitutions between ruthenium-cymene compounds can control protein versus DNA targeting and anticancer activity
Zenita Adhireksan et al.
NATURE COMMUNICATIONS (2014)
DMSO-Mediated Ligand Dissociation: Renaissance for Biological Activity of N-Heterocyclic-[Ru(η6-arene)Cl2] Drug Candidates
Malay Patra et al.
CHEMISTRY-A EUROPEAN JOURNAL (2013)
Evaluation of arene ruthenium(II) N-heterocyclic carbene complexes as organometallics interacting with thiol and selenol containing biomolecules
Luciano Oehninger et al.
DALTON TRANSACTIONS (2013)
Platinum-based drugs and proteins: Reactivity and relevance to DNA adduct formation
Odra Pinato et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2013)
TrxR inhibition and antiproliferative activities of structurally diverse gold N-heterocyclic carbene complexes
Riccardo Rubbiani et al.
MEDCHEMCOMM (2013)
Post-Protein-Binding Reactivity and Modifications of the fac-[Re(CO)3]+ Core
Fabio Zobi et al.
INORGANIC CHEMISTRY (2012)
Macromolecular ruthenium complexes as anti-cancer agents
Bianca M. Blunden et al.
POLYMER CHEMISTRY (2012)
Serum-protein interactions with anticancer Ru(III) complexes KP1019 and KP418 characterized by EPR
Naniye Cetinbas et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2010)
Bioorganometallic chemistry-from teaching paradigms to medicinal applications
Christian G. Hartinger et al.
CHEMICAL SOCIETY REVIEWS (2009)
Heterocyclic carbenes: Synthesis and coordination chemistry
F. Ekkehardt Hahn et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2008)
Antitumour metal compounds: more than theme and variations
Michael A. Jakupec et al.
DALTON TRANSACTIONS (2008)
Emerging Protein Targets for Anticancer Metallodrugs: Inhibition of Thioredoxin Reductase and Cathepsin B by Antitumor Ruthenium (II)-Arene Compounds
Angela Casini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
ESI mass spectrometry and X-ray diffraction studies of adducts between anticancer platinum drugs and hen egg white lysozyme
Angela Casini et al.
CHEMICAL COMMUNICATIONS (2007)
Systematic design of a targeted organometallic antitumor drug in pre-clinical development
Paul J. Dyson
CHIMIA (2007)
Phenylazo-pyridine and phenylazo-pyrazole chlorido ruthenium(II) arene complexes: Arene loss, aquation, and cancer cell cytotoxicity
Sarah J. Dougan et al.
INORGANIC CHEMISTRY (2006)
Half-sandwich arene ruthenium(II)-enzyme complex
IW McNae et al.
CHEMICAL COMMUNICATIONS (2004)
Inhibition of cancer cell growth by ruthenium(II) arene complexes
RE Morris et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
[Ru(eta(6)-p-cymene)Cl-2(pta)] (pta=1,3,5-triaza-7-phosphatricyclo[3.3.1.1]decane): a water soluble compound that exhibits pH dependent DNA binding providing selectivity for diseased cells
CS Allardyce et al.
CHEMICAL COMMUNICATIONS (2001)
Share Paper
